Use of deoxyinosine containing primers to balance primer efficiency in the amplification of nucleic acid molecules

• US 5,578,467 A
• Filed: 05/20/1994
• Issued: 11/26/1996
• Est. Priority Date: 01/10/1992
• Status: Expired due to Term

• Current Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Original Assignee: Life Technologies Incorporated (Thermo Fisher Scientific Incorporated)
• Inventors: Rashtchian, Ayoub, Schuster, David M.
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US08/246,921
• Time in Patent Office: 921 Days
• Field of Search: 435/6, 435/91.2, 435/91.52, 536/24.33, 935/78
• US Class Current: 435/91.2
• CPC Class Codes: C12Q 1/6832 Enhancement of hybridisation reaction
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6862 Ligase chain reaction [LCR]
• CPC Class Codes: C12Q 2521/107 RNA dependent DNA polymerase,(i.e. reverse transcriptase)
• CPC Class Codes: C12Q 2525/101 incorporating non-naturally occurring nucleotides, e.g. inosine
• CPC Class Codes: C12Q 2527/107 Temperature of melting, i.e. Tm
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

The present invention provides improved methods for amplifying a nucleic acid molecule. Specifically, the invention involves replacing at least one nucleotide of an oligonucleotide with a deoxyinosine residue, so as to more equalize the efficiency with which that oligonucloetide and a second oligonucleotide hybridize to a target molecule, and then amplifying the target molecule using, for example, the polymerase chain reaction. Improved amplification results from the improvement in the relative hybridization efficiencies.

Claims

1. An improved method for amplifying the concentration of a target nucleic acid molecule by using a first and second primer to form a double-stranded nucleic acid molecule, wherein said first primer hybridizes to a first strand of said double-stranded nucleic acid molecule, and said second primer hybridizes to a second strand of said double-stranded nucleic acid molecule, and wherein said primers exhibit different T_m s with respect to one another, when hybridized to said double-stranded nucleic acid molecule, said improved method comprising the steps:

(a) replacing at least one residue in at least one of said primers with at least one deoxyinosine, wherein said replacement equalizes the T_m s of the first and second primers with respect to one another, when hybridized to said double-stranded nucleic acid molecule;

(b) performing the template-dependent extension of said first primer, said first primer being hybridized to a first strand of said double-stranded molecule, wherein said extension forms a second strand of nucleic acid complementary to said first strand of said double-stranded nucleic acid molecule;

(c) performing the template-dependent extension of said second strand, by extending said second primer, said second primer being hybridized to said second strand of said double-stranded molecule, wherein said extension forms a copy of said first strand of said double-stranded nucleic acid molecule;

(d) performing the template-dependent extension of said copy of said first strand, to thereby form a copy of said second strand of said double-stranded nucleic acid molecule;

(e) repeating steps (b), (c) and (d), to thereby achieve said amplification of said target nucleic acid molecule.

2. The method of claim 1, wherein said nucleic acid molecule is an RNA molecule.

3. The method of claim 2, wherein said RNA molecule is single-stranded.

4. The method of claim 2, wherein said RNA molecule is double-stranded.

5. The method of claim 1, wherein said nucleic acid molecule is a DNA molecule.

6. The method of claim 5, wherein said DNA molecule is single-stranded.

7. The method of claim 5, wherein said DNA molecule is double-stranded.

8. The method of claim 1, wherein both of said primers contain at least one deoxyinosine residue.

9. The method of claim 1, wherein said nucleic acid molecule being amplified is polyadenylated at its 3'"'"' end, and wherein one of said primers contains a poly-T sequence, and the other of said primers contains at least one deoxyinosine residue.

10. The method of claim 1, wherein said nucleic acid molecule being amplified, copy thereof or complementary copy thereof, has been extended to contain a 3'"'"' sequence, and wherein one of said primers is capable of hybridizing to said 3'"'"' sequence, said primer containing at least one deoxyinosine residue.

11. The method of claim 1, wherein at least one of said primers is extended using a thermostable DNA polymerase.

12. The method of claim 11, wherein said thermostable DNA polymerase is Tag polymerase.

13. An improved method for amplifying the concentration of a target nucleic acid molecule by using a first and a second oligonucleotide primers, wherein said first and second primers hybridize to a nucleic acid molecule, such that they may be ligated to one another and thereby form said target molecule, and exhibit different T_m s with respect to one another, when hybridized to said nucleic acid molecule;

said improved method comprising the steps;

(a) replacing at least one residue in at least one of said primers with at least one deoxyinosine, wherein said replacement equalizes the T_m s of the first and second primers with respect to one another, when hybridized to said nucleic acid molecule;

(b) hybridizing said first and second primers to said nucleic acid molecule; and

(c) ligating said hybridized first and second primers to one another, wherein said ligation forms said target nucleic acid molecule.

14. The method of claim 13, wherein said target nucleic acid is a cDNA molecule.

15. The method of claim 13, wherein said oligonucleotides when ligated together form a primer, and wherein said primer is isothermally extended to produce a complement to said target molecule.

16. The method of claim 13 wherein the capacity of said oligonucleotides to ligate to one another is probative of the presence of a mutation.